Need help? Reach out to us
Back to library

Healthcare and pharma

Natco Pharma Regulatory Affairs Executive Interview: Rounds, Questions and Preparation

For Regulatory Affairs Executive roles at companies like Natco Pharma

Share with friends

Preparing together? Send them this role's questions.

https://www.cynchrony.in/library/natco-pharma-regulatory-affairs-executive

What the job involves

A Regulatory Affairs Executive in pharma ensures that a company's drug products comply with Indian and international regulations. Day to day, they prepare, compile, and submit dossiers to agencies like CDSCO, review change controls, and keep track of submissions and approvals. They also coordinate with R&D, manufacturing, and quality teams to gather data and respond to queries from regulators.

Role and Technical Knowledge

  1. 1

    What is the difference between CTD and eCTD, and why is eCTD preferred today?

    Explain that CTD is a paper or PDF format with five modules, while eCTD is an electronic XML-based format that allows lifecycle management. Mention that eCTD is preferred for faster review, easier tracking, and global harmonisation.

  2. 2

    Which Indian regulatory body approves new drugs and imports, and what is its role?

    Name CDSCO under the Ministry of Health and Family Welfare. Describe its functions: approving new drugs, clinical trials, imports, and licensing. Mention state drug controllers for manufacturing and sale licenses.

  3. 3

    What are the key sections of a Common Technical Document (CTD) dossier?

    List Module 1 (administrative and prescribing information), Module 2 (quality, nonclinical, clinical overviews and summaries), Module 3 (quality), Module 4 (nonclinical study reports), and Module 5 (clinical study reports). Emphasise that Module 1 is region-specific.

  4. 4

    What is the significance of ICH guidelines in regulatory affairs?

    Explain that ICH guidelines harmonise technical requirements for drug registration across regions. Mention key ones like Q1 (stability), Q7 (GMP), E6 (GCP), and M4 (CTD). Highlight that they reduce duplication and speed up approvals.

Practical Scenarios

  1. 5

    You notice a discrepancy in the stability data between two batches in a dossier you are compiling. What do you do?

    A strong answer shows you would not ignore it. You would flag it to your supervisor, check raw data and protocols, confirm if it is a transcription error or a real deviation, and document the resolution. Mention following data integrity principles.

  2. 6

    A regulatory authority asks for additional clarifications on a submitted dossier. How do you handle it?

    Describe a systematic approach: log the query, set a timeline, coordinate with relevant departments (R&D, QC, manufacturing) to gather responses, draft a clear reply, and get it reviewed before submission. Emphasise meeting the deadline.

  3. 7

    You are asked to prepare a dossier for a new market, but you have limited data. What steps do you take?

    Suggest starting with a gap analysis against that market's requirements, identifying missing data, and prioritising studies or justifications. Mention using existing data, literature, and possibly requesting waivers if allowed. Show awareness of risk and timelines.

  4. 8

    How would you ensure that a change in manufacturing process is properly reported to regulators?

    Explain that you would assess the change against guidelines (e.g., ICH Q12), determine if it is a major, moderate, or minor change, and file the appropriate variation or notification. Stress documentation, impact assessment, and timely submission.

Behavioural and Situational Questions

  1. 9

    Tell me about a time you had to meet a tight deadline with incomplete information.

    Use the STAR method. Focus on how you prioritised tasks, communicated with stakeholders, and delivered a workable solution. Highlight learning and outcome.

  2. 10

    Describe a situation where you had to work with a team to solve a complex problem.

    Show teamwork, clear communication, and your specific contribution. Mention how you coordinated with different functions like R&D or quality to achieve a common goal.

  3. 11

    How do you handle repetitive, detail-oriented work without losing focus?

    Talk about your methods: checklists, double-checking, taking short breaks, and understanding the importance of accuracy in regulatory submissions. Give an example from academics or internships.

  4. 12

    Why do you want to work in regulatory affairs, and why our company?

    Connect your interest in compliance and healthcare to the role. Research the company's product portfolio and regulatory footprint. Mention how you align with their values and want to contribute to bringing safe medicines to patients.

HR and Career Fit

  1. 13

    What do you know about our company and its regulatory achievements?

    Show you have researched the company's key products, markets, and any recent approvals or filings. Mention specific therapeutic areas or geographies they operate in. Avoid generic praise.

  2. 14

    Where do you see yourself in five years in regulatory affairs?

    Outline a growth path from executive to senior regulatory professional, possibly specialising in a region or product type. Show commitment to learning and taking on more responsibility.

  3. 15

    How do you stay updated with changing regulations?

    Mention sources like CDSCO website, ICH updates, industry newsletters, LinkedIn groups, and webinars. Give an example of a recent change you read about and how it could impact submissions.

  4. 16

    Are you comfortable working with cross-functional teams and tight timelines?

    Answer yes and give a brief example of a project where you coordinated with others under time pressure. Emphasise your organisational and communication skills.

Ready to try it for real?

Take a timed test or talk through a mock interview for this role, then see your scores.

This is practice material for Regulatory Affairs Executive roles, written with AI. It is not a list of questions Natco Pharma or any other company has asked.